Skip to content

Viatris VTRS Short-Term Investments

Short-Term Investments at other companies

Pfizer logo
PfizerPFE
$11.37B-28.4%
AMP
Amphastar PharmaceuticalsAMPH
$121.01M+124%
ARS Pharmaceuticals, Inc. logo
ARS Pharmaceuticals, Inc.SPRY
$176.65M-25.1%
Merck & Co. logo
Merck & Co.MRK
$375M-37.4%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$1.14B-14.5%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$60.3M

Other financials

Income statement

See full
Revenue$3.5B+8.1%
Gross profit$1.2B-0.3%
Operating income-$79.7M+97.2%
Net income$176.4M+106%
EPS (diluted)$0.15+106%

Balance sheet

See full
Cash & equivalents$1.8B+139%
Total debt$14.6B+1.0%
Total equity$14.7B-6.3%
Total assets$36.8B-4.3%

Cash flow

See full
Operating cash flow$388.3M-27.5%
CapEx$39.9M-6.3%
Free cash flow$348.4M-29.3%

Valuation

See full
Market cap$20.8B+92.8%
Enterprise value$33.61B+34.5%
P/S1.4×+0.7×

Profitability

See full
Gross margin34.4%-2.5pp
Operating margin1%
Net margin-2%-1.0pp
FCF margin12.3%-1.0pp

Returns & leverage

See full
Return on equity-2%-0.9pp
Debt / equity+0.1×
Current ratio1.6×-0.1×

Where this comes from

Reported directly by Viatris in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.

The official record: Viatris’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viatris's short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viatris's short-term investments?
Viatris (VTRS) reported short-term investments of $40.7M in Q4 2025.
How has Viatris's short-term investments changed year-over-year?
Viatris's short-term investments increased by 7.1% year-over-year, from $38M to $40.7M.
What is the long-term trend for Viatris's short-term investments?
Over 5 years (2020 to 2025), Viatris's short-term investments has grown at a 0.8% compound annual growth rate (CAGR), from $39.1M to $40.7M.
What does short-term investments mean?
Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.